Biguanide-functionalized peptide mimics effectively combat drug-resistant ESKAPE pathogens and meningitis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41365877.
- Also identified by DOI 10.1038/s41467-025-67044-5 and PMC identifier 12789443.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
ESKAPE pathogens-induced meningitis seriously threatens human health due to antimicrobial resistance and low permeability of blood-brain barrier (BBB). It's a promising strategy to combat drug-resistant pathogens using synthetic mimics of host defense peptide (HDP) bearing positive charges that are mainly provided by amine or guanidine. Here, we report that biguanide serves as a type of positively charged moiety to design HDP mimics. Biguanide exerts a stronger interaction with bacterial membrane phospholipids via bidentate hydrogen bonds than do amine and guanidine. The biguanide-functionalized HDP mimic, PBGProOx<sub>20</sub>, targets bacterial membrane phospholipids to show potent activity against all ESKAPE pathogens and does not induce antimicrobial resistance. PBGProOx<sub>20</sub> exhibits promising BBB-penetrating property and displays potent therapeutic effects in female mice full-thickness infection model, sub-cutaneous infection model, kidney infection model, peritonitis model, and meningitis model. This study provides a promising strategy for designing HDP mimics to combat ESKAPE pathogens and meningitis.
Medical subject headings
- Biguanides
- Anti-Bacterial Agents
- Meningitis, Bacterial
- Antimicrobial Cationic Peptides